Among synthetic analogues
of antimicrobial peptides (AMPs) under
investigation to address antimicrobial resistance, peptoids (
N
-alkylated oligoglycines) have been reported to act both
by membrane disruption and on intracellular targets. Here we gradually
introduced peptoid units into the membrane-disruptive undecapeptide
KKLLKLLKLLL to test a possible transition toward intracellular targeting.
We found that selected hybrids containing up to five peptoid units
retained the parent AMP’s α-helical folding, membrane
disruption, and antimicrobial effects against Gram-negative bacteria
including multidrug-resistant (MDR) strains of
Pseudomonas
aeruginosa
and
Klebsiella pneumoniae
while
showing reduced hemolysis and cell toxicities. Furthermore, some hybrids
containing as few as three peptoid units as well as the full peptoid
lost folding, membrane disruption, hemolysis, and cytotoxicity but
displayed strong antibacterial activity under dilute medium conditions
typical for proline-rich antimicrobial peptides (PrAMPs), pointing
to intracellular targeting. These findings parallel previous reports
that partially helical amphiphilic peptoids are privileged oligomers
for antibiotic development.